Clinicopatholgical and Molecular Features Associated With Programmed Cell Death Ligand 1 (PD-L1) Expression in Resected Lung Squamous Cell Carcinomas

被引：0
|
作者：
Huynh, Tiffany [1 ]
Chi, Anthony [1 ]
Uruga, Hironori [1 ]
Bozkurtlar, Emine [1 ]
Mark, Eugene [1 ]
Mino-Kenudson, Mari [1 ]
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
LABORATORY INVESTIGATION | 2015年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1916
引用
收藏
页码：478A / 478A
页数：1
相关论文
共 50 条
  • [41] Programmed Death-Ligand 1 (PD-L1) in Resected Lung Adenocarcinomas (LA) in a University Hospital
    Alvarez, Maria
    Vicente, Sandra
    Cebollero, Ana
    Pajares, Isabel
    Millastre, Esther
    Hernando, Jorge
    Puertolas, Teresa
    Alvarez, Ramiro
    Artal Cortes, Miguel
    Anton, Antonio
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S616 - S616
  • [42] Programmed death-ligand 1 (PD-L1) expression in pleomorphic carcinoma of the lung
    Imanishi, Naoko
    Hirai, Ayako
    Yoneda, Kazue
    Shimajiri, Shohei
    Kuwata, Taiji
    Tashima, Yuko
    Takeuchi, Masahiro
    Iwai, Yoshiko
    Ichiki, Yoshinobu
    Tanaka, Fumihiro
    JOURNAL OF SURGICAL ONCOLOGY, 2018, 117 (07) : 1563 - 1569
  • [43] Clinical impact of programmed cell death ligand 1 (PD-L1), programmed cell death 1 (PD-1), and CD8 expression in pancreatic cancer
    Shim, Hyun-Jeong
    Hwang, Jun-Eul
    Jung, Sook-In
    Lee, Kyung-Hwa
    Chung, Ik-Joo
    Cho, Sang-Hee
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [44] Programmed Death Cell Ligand 1 (PD-L1) Is Associated With Survival in Stage I Non-Small Cell Lung Cancer
    Sepesi, Boris
    Cuentas, Edwin Parra
    Canales, Jaime Rodriguez
    Behrens, Carmen
    Correa, Arlene M.
    Vaporciyan, Ara
    Weissferdt, Annikka
    Kalhor, Neda
    Moran, Cesar
    Swisher, Stephen
    Wistuba, Ignacio
    SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2017, 29 (03) : 408 - 415
  • [45] Comprehensive investigation of programmed death receptor ligand 1 (PD-L1) expression and associated molecular features in gastric cancer patients
    Liu, Xiaoqiao
    Lee, Jeeyun
    Kim, Kyoung-Mee
    Kim, Seung Tae
    Park, Se Hoon
    Kang, Won Ki
    Cristescu, Razvan
    Peter, Senaka
    CANCER RESEARCH, 2018, 78 (13)
  • [46] Immunohistochemical expression of programmed death ligand-1 (PD-L1) in oral squamous cell carcinoma and its clinicopathological correlation
    Kumar, M.
    Babu, S.
    Ratnakar, S.
    VIRCHOWS ARCHIV, 2020, 477 : S78 - S79
  • [47] Expressions of programmed death (PD)-1 and PD-1 ligand (PD-L1) in cervical intraepithelial neoplasia and cervical squamous cell carcinomas are of prognostic value and associated with human papillomavirus status
    Yang, Wen
    Lu, Yan-Ping
    Yang, Yi-Zhou
    Kang, Jia-Rui
    Jin, Yi-Duo
    Wang, Hong-Wei
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2017, 43 (10) : 1602 - 1612
  • [48] Programmed Cell Death Ligand (PD-L1) Expression in Stage II and III Lung Adenocarcinomas and Nodal Metastases
    Uruga, Hironori
    Bozkurtlar, Emine
    Huynh, Tiffany
    Muzikansky, Alona
    Hata, Aaron
    Gainor, Justin F.
    Mark, Eugene
    Engelman, Jeffrey A.
    Lanuti, Michael
    Mino-Kenudson, Mari
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S266 - S266
  • [49] Programmed Cell Death Ligand (PD-L1) Expression in Stage II and III Lung Adenocarcinomas and Nodal Metastases
    Uruga, Hironori
    Bozkurtlar, Emine
    Huynh, Tiffany G.
    Muzikansky, Alona
    Goto, Yasushi
    Gomez-Caraballo, Maria
    Hata, Aaron N.
    Gainor, Justin F.
    Mark, Eugene J.
    Engelman, Jeffrey A.
    Lanuti, Michael D.
    Mino-Kenudson, Mari
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (03) : 458 - 466
  • [50] Enhanced programmed death 1 (PD-1) and PD-1 ligand (PD-L1) expression in patients with actinic cheilitis and oral squamous cell carcinoma
    de Souza Malaspina, Tatiana Salles
    Gasparoto, Thais Helena
    Sales Nogueira Costa, Maria Renata
    de Melo, Edgard Franco, Jr.
    Valerio Ikoma, Maura Rosane
    Damante, Jose Humberto
    Cavassani, Karen Angelica
    Garlet, Gustavo Pompermaier
    da Silva, Joao Santana
    Campanelli, Ana Paula
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2011, 60 (07) : 965 - 974
12345